New York Life Investment Management LLC Acquires 78 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

New York Life Investment Management LLC grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 0.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,102 shares of the biotechnology company’s stock after buying an additional 78 shares during the quarter. New York Life Investment Management LLC’s holdings in Axon Enterprise were worth $2,010,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CWM LLC grew its stake in Axon Enterprise by 1.8% in the 3rd quarter. CWM LLC now owns 2,669 shares of the biotechnology company’s stock worth $531,000 after acquiring an additional 46 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its stake in Axon Enterprise by 2.4% in the 1st quarter. Mercer Global Advisors Inc. ADV now owns 2,499 shares of the biotechnology company’s stock worth $562,000 after acquiring an additional 59 shares in the last quarter. Signaturefd LLC grew its stake in Axon Enterprise by 16.1% in the 3rd quarter. Signaturefd LLC now owns 475 shares of the biotechnology company’s stock worth $95,000 after acquiring an additional 66 shares in the last quarter. O Shaughnessy Asset Management LLC grew its stake in Axon Enterprise by 5.4% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 1,288 shares of the biotechnology company’s stock worth $290,000 after acquiring an additional 66 shares in the last quarter. Finally, Advisor Partners II LLC grew its stake in Axon Enterprise by 2.6% in the 4th quarter. Advisor Partners II LLC now owns 2,632 shares of the biotechnology company’s stock worth $437,000 after acquiring an additional 66 shares in the last quarter. 76.52% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on AXON shares. Raymond James increased their price objective on shares of Axon Enterprise from $223.00 to $233.00 and gave the company an “outperform” rating in a research note on Wednesday, November 8th. JMP Securities increased their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research note on Tuesday. TheStreet upgraded shares of Axon Enterprise from a “c” rating to a “b” rating in a research note on Tuesday, November 7th. Needham & Company LLC reiterated a “buy” rating and set a $240.00 price objective on shares of Axon Enterprise in a research note on Friday, February 2nd. Finally, Barclays increased their price objective on shares of Axon Enterprise from $247.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, January 2nd. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $255.36.

Get Our Latest Report on Axon Enterprise

Axon Enterprise Trading Up 0.8 %

NASDAQ AXON opened at $259.46 on Wednesday. The company has a market capitalization of $19.44 billion, a PE ratio of 133.06 and a beta of 0.90. The company has a fifty day moving average of $249.67 and a 200 day moving average of $221.28. Axon Enterprise, Inc. has a 1 year low of $168.30 and a 1 year high of $262.95. The company has a debt-to-equity ratio of 0.44, a current ratio of 3.15 and a quick ratio of 2.78.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings data on Tuesday, November 7th. The biotechnology company reported $0.71 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.31. The business had revenue of $413.60 million during the quarter, compared to the consensus estimate of $393.77 million. Axon Enterprise had a net margin of 9.96% and a return on equity of 12.63%. Research analysts forecast that Axon Enterprise, Inc. will post 2.29 earnings per share for the current year.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 635 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $230.38, for a total value of $146,291.30. Following the completion of the transaction, the insider now owns 236,020 shares in the company, valued at $54,374,287.60. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, insider Jeffrey C. Kunins sold 635 shares of the business’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $230.38, for a total transaction of $146,291.30. Following the completion of the sale, the insider now owns 236,020 shares of the company’s stock, valued at $54,374,287.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 41,167 shares of the business’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $217.33, for a total transaction of $8,946,824.11. Following the sale, the insider now directly owns 236,655 shares of the company’s stock, valued at approximately $51,432,231.15. The disclosure for this sale can be found here. Over the last quarter, insiders sold 85,343 shares of company stock worth $19,964,734. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.